| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06679881 | Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis… | Hereditary Angioedema (HAE) | Recruiting |
| NCT07266805 | Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for… | Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) | Recruiting |
| NCT06669754 | Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema… | Hereditary Angioedema (HAE) | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05396105 | Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients… | Hereditary Angioedema | Enrolling by Invitation |